Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Liver Diseases × Injections × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 17 Breast Neoplasms 17 Advanced Solid Tumors 11 Advanced Solid Tumor 11 Myelodysplastic Syndromes 9 Carcinoma, Non-Small-Cell Lung 8 Stomach Neoplasms 5 Recurrence 5 Prostatic Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 5 Carcinoma, Hepatocellular 5 Uterine Cervical Neoplasms 4 Solid Tumor 4 Neoplasms 4 Myeloproliferative Disorders 4 Triple Negative Breast Neoplasms 3 Solid Tumors 3 Small Cell Lung Carcinoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Multiple Myeloma 3 Lymphoma 3 Leukemia, Myelomonocytic, Chronic 3 Advanced Solid Tumour 3 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic Neoplasms 2 Neuroendocrine Tumors 2 Neoplasm Metastasis 2 Metastatic Castration-resistant Prostate Cancer (mCRPC) 2 Melanoma 2

Interventions

atezolizumab 2 Bevacizumab 2 pembrolizumab 1 lenvatinib 1 camrelizumab 1 User-Centered Design 1 Neuropsychological Tests 1 Neoadjuvant Therapy 1 Liver Transplantation 1 Lead 1 Injections 1 Control Groups 1 Catheter Ablation 1 Antibodies 1 Adjuvants, Pharmaceutic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04727307 2025-09-30

AB-LATE02

University Hospital, Montpellier

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡